PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 27 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Triterpenoids (7-deacetoxy-7-oxogedunin and 2-hydroxymethyl-2,3,22,23-tetrahydroxy-2,6,10,15,19,23-hexamethyl-6,10,14,18-tetracosatetraene) showed moderate in vitro antiplasmodial activity [PMID:18220356]. Extracts showed IC50 values below 30 microg/mL against both chloroquine sensitive and resistant strains [PMID:15173997].
Acute intravenous administration of ethanolic leaf extract elicited hypotensive responses in anaesthetised rats, and sub-chronic treatment averted high blood pressure development in weanling Dahl salt-sensitive rats [PMID:19575078].
Extracts from the wood displayed uterotonic activity in guinea pig uterine smooth muscle in vitro [PMID:11108547].
Ethanol and water extracts of the bark showed anti-inflammatory activity against COX-1 and COX-2 enzymes [PMID:23276783].
Safety & adverse effects
Pregnancy & lactation
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 18220356 (2008) — Antiplasmodial triterpenoids from Ekebergia capensis. · Journal of natural products
- 2.PMID: 29527579 (2018) — Foliar secretory structures in Ekebergia capensis (Meliaceae). · Heliyon
- 3.PMID: 41029656 (2025) — Modelling the distribution of Ekebergia capensis sparrm. (Meliaceae) under the current and future climate change scenarios in Ethiopia. · BMC ecology and evolution
- 4.PMID: 19575078 (2009) — Cardiovascular effects of Ekebergia capensis Sparrm (Meliaceae) ethanolic leaf extract in experimental animal paradigms. · Cardiovascular journal of Africa
- 5.PMID: 11108547 (2000) — The uterotonic activity of compounds isolated from the supercritical fluid extract of Ekebergia capensis.